<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Embryonic development of multilineage hematopoiesis requires the precisely regulated expression of lineage-specific transcription factors, including <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-1 (encoded by Runx1; also known as CBFA-2 or PEBP-2alphaB) </plain></SENT>
<SENT sid="1" pm="."><plain>In vitro studies and findings in human diseases, including <z:hpo ids='HP_0001909'>leukemias</z:hpo>, <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> and familial <z:e sem="disease" ids="C0005818" disease_type="Disease or Syndrome" abbrv="">platelet disorder</z:e> with predisposition to <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>), suggest that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-1 has a pivotal role in adult hematopoiesis </plain></SENT>
<SENT sid="2" pm="."><plain>However, this role has not been fully uncovered in vivo because of the <z:mp ids='MP_0008762'>embryonic lethality</z:mp> of Runx1 knockout in mice </plain></SENT>
<SENT sid="3" pm="."><plain>Here we assess the requirement of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-1/Runx1 in adult hematopoiesis using an inducible gene-targeting method </plain></SENT>
<SENT sid="4" pm="."><plain>In the absence of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-1, hematopoietic progenitors were fully maintained with <z:mpath ids='MPATH_458'>normal</z:mpath> myeloid cell development </plain></SENT>
<SENT sid="5" pm="."><plain>However, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-1-deficient bone marrow showed inhibition of megakaryocytic maturation, increased hematopoietic progenitor cells and defective T- and B-lymphocyte development </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-1 is thus required for maturation of megakaryocytes and differentiation of T and B cells, but not for maintenance of hematopoietic stem cells (<z:chebi fb="15" ids="50443">HSCs</z:chebi>) in adult hematopoiesis </plain></SENT>
</text></document>